Recent News

Concert Pharmaceuticals Announces Initiation of CTP-730 Phase 1 Clinical Trial Under Celgene Collaboration

September 17, 2014
Not Flagship

Joule to Team with DNV GL for Commercial Validation of Transformative CO2-to-Fuels Production Process

September 17, 2014
Not Flagship

Dr. Mark Roskey Joins Quanterix Leadership Team

September 16, 2014
Not Flagship

Seres Health Presents Final Data for Study of SER-109 in Recurrent Clostridium difficile Infection at ICAAC 2014 Conference

September 8, 2014
Not Flagship

Joule and Scatec Solar ASA to Align for Photovoltaic-Powered Solar Fuel Production

September 5, 2014
Not Flagship

CPI Announces Finalists For 2013 Polyurethane Innovation Award

September 5, 2014
Not Flagship

Avedro Acquires Assets of IROC Innocross AG, Including its UV-X Line of Cross-Linking Devices

September 3, 2014
Not Flagship

BIND Therapeutics Appoints Two New Board Members

September 3, 2014
Not Flagship

Oasys Water Continues Growth and Commercialization Momentum in Global Markets

September 2, 2014
Not Flagship

Seres Health to Present Clinical Findings at ICAAC 2014 Conference

August 28, 2014
Not Flagship

Joule to Host Strategic Seminar on Climate Change in Norway, Featuring Jeffrey Sachs

August 28, 2014
Not Flagship

Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration

August 26, 2014
Not Flagship

Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner

August 25, 2014
Is Flagship Story

Joule Achieves Industry First With A 100% Increase In Photosynthetic Efficiency

August 15, 2014
Not Flagship

Eleven Biotherapeutics Reports Second Quarter 2014 Financial Results

August 13, 2014
Not Flagship

Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation

August 13, 2014
Not Flagship

Seventh Sense Biosystems Closes $16 Million Series B Financing

August 13, 2014
Not Flagship

Allergan Acquires LiRIS® Program from TARIS Biomedical®

August 13, 2014
Not Flagship

Acceleron Pharma Reports Second Quarter 2014 Financial Results

August 12, 2014
Not Flagship

Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update

August 12, 2014
Not Flagship

Joule to Present Transformative Climate Change Solution at Arendal Week

August 12, 2014
Not Flagship

T2 Biosystems Announces Pricing of Initial Public Offering

August 7, 2014
Not Flagship

Is this the next big leap for organ transplants?

August 7, 2014
Not Flagship

BIND Therapeutics Reports Second Quarter 2014 Financial Results

August 7, 2014
Not Flagship

Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386

July 21, 2014
Not Flagship

Concert Pharmaceuticals Announces FDA Lifts Partial Clinical Hold for CTP-354, A Novel Drug Candidate for Spasticity

July 16, 2014
Not Flagship

Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data

July 16, 2014
Not Flagship

Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner

July 14, 2014
Is Flagship Story

Acceleron Pharma Appoints Terrence C. Kearney to its Board of Directors

July 14, 2014
Not Flagship

Concert Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for CTP-499

July 8, 2014
Not Flagship

Seres Health Announces Allowance for Key Patent on the Use of Synergistic Bacterial Compositions

July 7, 2014
Not Flagship

Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido

July 1, 2014
Not Flagship

Joule First to Gain US EPA Clearance for Commercial Use of Modified Cyanobacteria for Fuel Production

July 1, 2014
Not Flagship

Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer

June 24, 2014
Not Flagship

Syros Pharmaceuticals Co-Founders’ Novel Approach to Cancer Regulation Published in Nature

June 23, 2014
Not Flagship

Clinical Chemistry Study Reports on Use of T2MR to Evaluate Hemostasis in Whole Blood

June 23, 2014
Not Flagship

BIND Therapeutics and Roche Collaborate on Discovery of Novel Nanomedicines

June 19, 2014
Not Flagship

Selecta Biosciences to Accelerate Program for Novel Dual Action Vaccine for Malaria

June 17, 2014
Not Flagship

Selecta Biosciences Enters Into Exclusive License Agreement with 3SBio to Develop Drug Candidate to Treat Gout

June 17, 2014
Not Flagship

Selecta Accelerates Immune Tolerance Therapeutics and Announces New Product Candidate, SEL-212, for Refractory and Tophaceous Gout

June 17, 2014
Not Flagship

Moderna Named to CNBC Disruptor 50 List

June 17, 2014
Not Flagship

Agios Pharmaceuticals Announces Orphan Drug Designation of AG-221 for Treatment of Acute Myelogenous Leukemia

June 16, 2014
Not Flagship

Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration

June 13, 2014
Not Flagship

Moderna Announces Expansion to New Facility in Kendall Square

June 12, 2014
Not Flagship

Avedro Becomes Exclusive Global Supplier of MedioCROSS®Riboflavin for Corneal Cross-Linking

June 12, 2014
Not Flagship

Syros Pharmaceuticals Appoints Genomics Entrepreneur Jorge Conde to Dual Role as Chief Financial Officer and Chief Product Officer

June 10, 2014
Not Flagship

Kevin Hrusovsky Joins Quanterix as Executive Chairman

June 10, 2014
Not Flagship

Seres Health Closes Series B Financing and Enters into a Research Agreement with Mayo Clinic

June 9, 2014
Not Flagship

Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for the Potential Treatment of PK Deficiency, a Rare, Hemolytic Anemia

June 9, 2014
Not Flagship

Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis

June 9, 2014
Not Flagship

Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation

June 5, 2014
Is Flagship Story

T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Dx and T2Candida

June 3, 2014
Not Flagship

Seres Health Appoints Former Merck Senior Executive, Roger J. Pomerantz, M.D., F.A.C.P., as Chief Executive Officer and Chairman

June 2, 2014
Not Flagship

Quanterix Selected as a Red Herring Top 100 North America Winner

May 29, 2014
Not Flagship

Novomer Announces Commercial Launch of Converge® Polyols for Broad Use in Polyurethanes Industry

May 29, 2014
Not Flagship

Charles Rowland Elected to BIND Therapeutics Board of Directors

May 28, 2014
Not Flagship

Moderna Forms Technology Advisory Board to Provide Expertise for the Company's GMP Manufacturing Strategy

May 21, 2014
Not Flagship

Joule Names Tom Einar Jensen Head of Corporate Development

May 21, 2014
Not Flagship

Eleven Biotherapeutics Reports Fiscal First Quarter 2014 Financial Results

May 15, 2014
Not Flagship

Joule Achieves ASTM Compliance for Sustainable Diesel, Jet Fuel

May 15, 2014
Not Flagship

Acceleron Pharma Reports First Quarter 2014 Financial Results

May 15, 2014
Not Flagship

Avedro Welcomes Robert J. Palmisano to its Board of Directors

May 14, 2014
Not Flagship

Concert Pharmaceuticals Reports First Quarter 2014 Financial Results

May 14, 2014
Not Flagship

Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer

May 14, 2014
Not Flagship

BG Medicine Reports First Quarter 2014 Financial Results

May 14, 2014
Not Flagship

Receptos Reports First Quarter 2014 Financial Results

May 12, 2014
Not Flagship

Agios Pharmaceuticals Reports First Quarter 2014 Financial Results

May 8, 2014
Not Flagship

BIND Therapeutics Reports First Quarter 2014 Financial Results and Updates BIND-014 Clinical Development Plan

May 8, 2014
Not Flagship

Eleven Biotherapeutics Presents Data on Novel Protein Therapeutics for Treatment of Front and Back of Eye Diseases at ARVO 2014 Annual Meeting

May 6, 2014
Not Flagship

Eleven Biotherapeutics Appoints Gary Sternberg, M.D., M.B.A., as Executive Vice President Corporate and Business Development

May 5, 2014
Not Flagship

Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting

April 28, 2014
Not Flagship

Editas Medicine Co-founders Present Novel Methods for Improving Genome Editing Specificity in Two Nature Biotechnology Papers

April 25, 2014
Not Flagship

Concert Pharmaceuticals Presents Positive 48-Week Results from Phase 2 Clinical Trial of CTP-499 in Diabetic Kidney Disease

April 25, 2014
Not Flagship

Avedro Announces Canadian Approval for its KXL II ™ Advanced Cross-Linking System

April 23, 2014
Not Flagship

Acceleron and Celgene Announce Interim Clinical Data for Sotatercept Demonstrating Dose Dependent Increases in Hemoglobin in Patients with End Stage Renal Disease on Hemodialysis

April 23, 2014
Not Flagship

Agios Initiates Phase 1 Study of AG-348, a First-in-class PKR Activator, for Pyruvate Kinase Deficiency

April 17, 2014
Not Flagship

TransMedics® Announced Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT

April 14, 2014
Not Flagship

Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director

April 14, 2014
Not Flagship

Oasys Water Named 2014 Water Technology Company of the Year

April 8, 2014
Not Flagship

Oasys Water Honored as One of Bloomberg’s 2014 New Energy Pioneers at BNEF’s Future of Energy Summit

April 8, 2014
Not Flagship

BIND Therapeutics Presents Clinical Data Highlighting Unique Attributes of Lead Cancer Drug Candidate, BIND-014, at AACR 2014 Annual Meeting

April 7, 2014
Not Flagship

Agios Announces Initial Phase 1 Data Demonstrating Clinical Activity of AG-221, First-in-Class Inhibitor of IDH2 Mutations, in Patients with Advanced Blood Cancers

April 6, 2014
Not Flagship

T2 Biosystems Appoints Michael Pfaller, MD, Chief Medical Officer

April 3, 2014
Not Flagship

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock

April 2, 2014
Not Flagship

Concert Pharmaceuticals Reports Year End 2013 Financial Results

March 31, 2014
Not Flagship

BIND Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

March 25, 2014
Not Flagship

Seres Health to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference

March 25, 2014
Not Flagship

Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept and ACE-536 Therapeutic Potential in Beta-thalassemia and Myelodysplastic Syndromes

March 24, 2014
Not Flagship

Agios Enrolls First Patient in Phase 1 Study of AG-120 in Advanced Solid Tumors with an IDH1 Mutation

March 24, 2014
Not Flagship

BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy

March 20, 2014
Not Flagship

Concert Pharmaceuticals Announces CTP-499 Late Breaking Presentation at the National Kidney Foundation 2014 Spring Clinical Meeting

March 19, 2014
Not Flagship

Agios Announces Enrollment of First Patient in Phase 1 Study of AG-120 in Advanced Hematologic Malignancies with an IDH1 Mutation

March 19, 2014
Not Flagship

Black Duck Appoints Mark Fusco to its Board of Directors

March 18, 2014
Not Flagship

Concert Pharmaceuticals Appoints Wendell Wierenga to Board of Directors

March 14, 2014
Not Flagship

Quanterix’s Simoa Technology to Detect Blood Biomarker for Concussion in Hockey Players

March 14, 2014
Not Flagship

Tangent Medical Appoints Eric Sandberg to Company President

March 13, 2014
Not Flagship

Flagship Ventures Partner David Berry Named a 2014 Young Global Leader by the World Economic Forum

March 11, 2014
Is Flagship Story

BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers

March 10, 2014
Not Flagship

Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer

March 6, 2014
Not Flagship

Tetraphase Reports Fourth-Quarter and Full-Year 2013 Financial Results

March 6, 2014
Not Flagship

Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

March 6, 2014
Not Flagship

Receptos Reports Fourth Quarter and Year End 2013 Operational and Financial Results

March 5, 2014
Not Flagship

Eleven Biotherapeutics Reports Clinical and Regulatory Updates for EBI-005

March 4, 2014
Not Flagship

Eleven Biotherapeutics Appoints Paul Chaney to Its Board of Directors

March 3, 2014
Not Flagship

BIND Therapeutics Promotes Key Executives: Organization Positioned for Continued Growth

March 3, 2014
Not Flagship

Joule Appoints David Anton Chief Technology Officer

February 28, 2014
Not Flagship

Joule Names Paul Snaith as New President and CEO

February 20, 2014
Not Flagship

Eleven Biotherapeutics Initiates Pivotal Phase 3 Clinical Study with EBI-005 in Dry Eye Disease

February 18, 2014
Not Flagship

Concert Pharmaceuticals Announces Pricing of Initial Public Offering

February 13, 2014
Not Flagship

Pronutria® Announces Launch of Two Clinical Trials

February 13, 2014
Not Flagship

Tangent Medical Receives ISO 13485 Certification

February 12, 2014
Not Flagship

Eleven Biotherapeutics Prices Initial Public Offering

February 6, 2014
Not Flagship

Tetraphase Pharmaceuticals Names Craig Thompson Chief Operating Officer

February 4, 2014
Not Flagship

T2 Biosystems Awarded Top Honor as ‘Most Promising Company’ at Personalized Medicine World Conference 2014

January 30, 2014
Not Flagship

Concert Pharmaceuticals Announces the Appointment of Ryan Daws as Chief Financial Officer

January 23, 2014
Not Flagship

Quanterix Awarded Grant from GE and the NFL’s Head Health Challenge

January 23, 2014
Not Flagship

Renewable Energy Group Enters Industrial Biotech with Acquisition of LS9

January 22, 2014
Not Flagship

Oasys Water Expands to Support Commercialization and Manufacturing of Industry-Pioneering Forward Osmosis Systems

January 15, 2014
Not Flagship

Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment

January 14, 2014
Not Flagship

Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics(TM) for Rare Diseases

January 13, 2014
Not Flagship

Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile

January 13, 2014
Not Flagship

T2 Biosystems and Collaborators Announce Discovery of Novel Clot Structure Biology Enabled by T2HemoStat

January 9, 2014
Not Flagship

Selventa Receives Patent for Extracting Knowledge From Biological Networks

January 7, 2014
Not Flagship

Blend Therapeutics Appoints Richard Wooster, Ph.D., as Chief Scientific Officer

January 6, 2014
Not Flagship

Eleven Biotherapeutics Adds Biotech Industry Veterans to Management Team and Board

January 2, 2014
Not Flagship

Eleven Biotherapeutics Files Registration Statement for Proposed Initial Public Offering

January 2, 2014
Not Flagship

Eleven Biotherapeutics Establishes Scientific Advisory Board to Guide Ophthalmic Pipeline and Technology Development

December 23, 2013
Not Flagship

Acceleron Earns $7 Million Milestone Payment for Celgene's Initiation of Sotatercept Phase 2 Clinical Trial in Patients with End Stage Renal Disease on Hemodialysis

December 18, 2013
Not Flagship

Syros Pharmaceuticals Announces Publication of Important Scientific Studies Related to Company's Industry-Leading Gene Control Platform

December 18, 2013
Not Flagship

Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors

December 17, 2013
Not Flagship

Dr. Nathanael Gray, a Syros Pharmaceuticals Scientific Founder, Honored with 2013 Meyenburg Cancer Research Award

December 16, 2013
Not Flagship

Oasys Water Culminates Year with New Partnerships and Sale of World’s Largest, Most Capable Forward Osmosis System

December 12, 2013
Not Flagship

Agios Advances Cancer Metabolism Collaboration with Celgene

December 11, 2013
Not Flagship

Mascoma’s Technology Surpasses One Billion Gallons

December 11, 2013
Not Flagship

T2 Biosystems Strengthens Management Team as Company Prepares for Launch of Flagship T2CandidaTM Diagnostic Test

December 11, 2013
Not Flagship

BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test

December 10, 2013
Not Flagship

Saudi Aramco Energy Ventures LLC Announces an Equity Investment into Novomer Inc.

December 10, 2013
Not Flagship

Receptos and Ono Pharmaceuticals Expand Collaboration Agreement to Include Transfer of Receptos GPCR Technology Platform

December 10, 2013
Not Flagship

Acceleron and Celgene Report New Interim Clinical Data from Phase 2 Trial of Sotatercept in Beta-Thalassemia at 2013 American Society of Hematology Annual Meeting

December 9, 2013
Not Flagship

Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting

December 9, 2013
Not Flagship

Selecta Biosciences Announces Successful Pre-clinical Study of SEL-201 As An Antigen-Specific Immune Tolerance Treatment for Patients Receiving Factor VIII Therapy

December 9, 2013
Not Flagship

Selecta Biosciences Announces Allowance of the First in a Series of Patents on the Induction of Antigen-Specific Immune Tolerance Using Selecta’s Novel Immunotherapies

December 9, 2013
Not Flagship

Receptos to Initiate Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis

December 5, 2013
Not Flagship

Software Industry Veteran Lou Shipley Named CEO of Black Duck Software

December 4, 2013
Not Flagship

Acceleron Pharma Provides Update on Clinical Pipeline at Piper Jaffray Healthcare Conference

December 3, 2013
Not Flagship

Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth

December 2, 2013
Not Flagship

Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT

December 2, 2013
Not Flagship

BIND Therapeutics Co-Founders Demonstrate Ability to Cross Biological Barriers with Targeted Therapeutic Nanoparticles

November 27, 2013
Not Flagship

Avedro Announces FDA Priority Review Status for Corneal Cross-linking New Drug Application

November 25, 2013
Not Flagship

Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders

November 25, 2013
Not Flagship

Editas Medicine Created to Discover and Develop Novel Class of Genome Editing Therapeutics

November 25, 2013
Not Flagship

Flagship Takes a Stab at Microbiome Therapy With Seres Health

November 21, 2013
Not Flagship

Flagship VentureLabs™ Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome

November 21, 2013
Not Flagship

Syros Pharmaceuticals Appoints Stéphane Bancel to Board of Directors

November 21, 2013
Not Flagship

Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics™

November 20, 2013
Not Flagship

Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs

November 20, 2013
Not Flagship

Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure

November 19, 2013
Not Flagship

Avedro and the University of Rostock (Germany) Announce Exclusive Intellectual Property Agreement

November 14, 2013
Not Flagship

BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer

November 14, 2013
Not Flagship

Tetraphase Reports Third-Quarter 2013 Financial Results

November 14, 2013
Not Flagship

Avedro Announces the Start of Two New US FDA Trials for Accelerated Cross-linking

November 12, 2013
Not Flagship

TransMedics, Inc. Appointed Jeffrey E. Young as Chief Financial Officer

November 8, 2013
Not Flagship

Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock

November 7, 2013
Not Flagship

Black Duck Maintains Rapid Pace With Record-Breaking Third Quarter

November 7, 2013
Not Flagship

Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results

November 7, 2013
Not Flagship

Mascoma Adds Two Industry Experts to Board of Directors

November 6, 2013
Not Flagship

SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test

November 6, 2013
Not Flagship

BG Medicine Reports 2013 Third Quarter Financial Results

November 6, 2013
Not Flagship

Avedro Announces CE Mark Clearance for its KXL II ™ Advanced Cross-linking System

November 5, 2013
Not Flagship

EcoSense Lighting Closes $15M Financing Round Amidst Rapid Growth

November 5, 2013
Not Flagship

BIND Awarded the RUSNANOPRIZE 2013 for Innovative Development of Nanomedicine

November 4, 2013
Not Flagship

Seventh Sense Biosystems Receives CE Mark Approval for its Touch Activated Phlebotomy Blood Collection and Testing System

November 4, 2013
Not Flagship

Moderna Therapeutics Named to the World Economic Forum's Community of "Global Growth Companies"

October 24, 2013
Not Flagship

Flagship VentureLabs™ Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients

October 22, 2013
Not Flagship

Flagship’s Pronutria Emerges to Make Medicines and Medical Foods

October 22, 2013
Not Flagship

Moderna Therapeutics Announces Expansion to New Headquarters and Laboratories at 200 Tech Square

October 17, 2013
Not Flagship

T2 Biosystems Announces Publication of Data Demonstrating T2Candida® Identifies Candida Significantly Faster than Current Methods

October 17, 2013
Not Flagship

TARIS Biomedical® Enters Research Collaboration with AstraZeneca for Improved Bladder Cancer Treatments

October 16, 2013
Not Flagship

Quanterix Announces Key Patents Issued for Simoa Platform

October 16, 2013
Not Flagship

DARPA Awards Moderna Therapeutics A Grant For Up To $25 Million To Develop Messenger RNA Therapeutics™

October 2, 2013
Not Flagship

BG Medicine Announces Preliminary Decision by CMS on Reconsideration of Reimbursement for BGM Galectin-3 Test

September 30, 2013
Not Flagship

Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors

September 26, 2013
Not Flagship

Moderna Therapeutics Named a "Fierce 15" Biotech Company for 2013

September 24, 2013
Not Flagship

Visterra Named One of the “Fierce 15” Leading Biotech Companies of 2013

September 24, 2013
Not Flagship

Novomer Catalytic Process Using Waste CO2 and Shale Gas Targets $20 Billion Market and up to 110% Carbon Footprint Reduction

September 24, 2013
Not Flagship

Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 in Advanced Hematologic Malignancies with an IDH2 Mutation

September 23, 2013
Not Flagship

BG Medicine, Inc. Welcomes Galectin-3 Clinical Research Data From the PROTECT Study Conducted at Massachusetts General Hospital Demonstrating Predictive Value of Adverse Outcomes in Heart Failure Patients

September 23, 2013
Not Flagship

Eleven Biotherapeutics Presents Positive Clinical Data on EBI‐005, a Targeted Protein Therapeutic for

September 20, 2013
Not Flagship

BIND Therapeutics Announces Pricing of Initial Public Offering

September 19, 2013
Not Flagship